Commercial Medical Devices

UK confirms long-term CE mark recognition for medical devices

The government will continue accepting CE-marked medical devices and IVDs in Great Britain, with UKCA marking remaining available as the domestic route.

Dalia IvanovaOctober 22, 20265 min read10 views

A conceptual editorial scene shows medical devices and diagnostic tests linked to an abstract approval gateway, illustrating long-term regulatory recognition and supply continuity.

The UK government has confirmed that CE-marked medical devices and in vitro diagnostic devices will continue to be accepted in Great Britain on a long-term basis. The decision means products already assessed and approved for the European market will not require an additional UK approval route to reach patients and the NHS.

The confirmation covers a broad range of medical technologies, including insulin pumps, replacement joints, diagnostic tests and surgical equipment. It follows a public consultation that ran from 16 February to 10 April 2026 and received more than 1,000 responses from patients, healthcare organisations, industry and other stakeholders. The scope includes products used in diagnosis, treatment and surgery.

Supply and access

More than 90% of medical devices currently registered for use in Great Britain carry a CE mark, according to the announcement. These devices have been assessed and approved for the European market, and that approval has been recognised as providing access to the Great Britain market. Continued recognition is intended to help maintain safe, uninterrupted access to treatments and technologies that patients and the NHS rely on.

The government said the approach avoids duplication for manufacturers and helps maintain stable supply and patient access. The decision was widely anticipated following the consultation, which gathered views from patients, healthcare organisations, industry and others on the future recognition of CE-marked devices.

Two routes remain

CE marking will sit alongside the UKCA marking route, which continues to operate as the domestic approval pathway for devices placed on the market in Great Britain. The confirmation therefore preserves CE marking as an accepted long-term route while retaining UKCA as the UK's own system.

  • CE-marked medical devices and IVDs remain accepted in Great Britain on a long-term basis.
  • UKCA marking continues as the domestic route for devices placed on the Great Britain market.
  • More than 90% of registered devices in Great Britain currently carry a CE mark.

For manufacturers, the outcome removes the need to duplicate approval work for devices already approved for the EU market. For patients and providers, it supports continuity of supply across devices used in routine care, specialist treatment and diagnosis. The government's statement focused on continuity for products already registered and on avoiding duplicative requirements for manufacturers. Guidance on placing UKCA- or CE-marked products on the market in Great Britain remains available.